High Efficiency
Semaglutide
Proven Weight Loss
Starting at $270
Semaglutide is the most studied GLP-1 medication for weight loss — with proven cardiovascular benefits and the longest track record of safety and efficacy.
GLP-1 receptor agonist
Semaglutide mimics the body's natural GLP-1 hormone — slowing gastric emptying, reducing hunger signals, and improving insulin secretion. It's the most thoroughly studied GLP-1 medication, with over a decade of clinical data and millions of patient-years of real-world use.
~15% average weight loss
In the STEP trial program, semaglutide produced 14.9% average weight loss at 68 weeks — the first GLP-1 medication to demonstrate that degree of efficacy in patients without diabetes. Results are sustained over 2+ years with continued use.
20% MACE reduction
The SELECT trial showed semaglutide reduces major adverse cardiovascular events (heart attack, stroke, CV death) by 20% in patients with established heart disease. It's the first and only weight-loss medication with proven cardiovascular protection.
The Science, in Full Detail
We believe patients deserve to understand exactly how and why their treatment works.
One receptor. One weekly injection.
Semaglutide is a GLP-1 receptor agonist — it mimics the natural gut hormone that regulates appetite and glucose metabolism. By activating this single pathway, it produces clinically meaningful weight loss with a well-understood safety profile.
Get StartedGLP-1 Pathway
- Slows gastric emptying — food moves through your stomach more slowly, extending fullness
- Signals the brain's satiety centers to reduce hunger and 'food noise'
- Stimulates insulin release in a glucose-dependent, safe manner — no risk of hypoglycemia
- Reduces glucagon secretion, preventing inappropriate blood sugar spikes
- Improves endothelial function and reduces inflammation — direct cardiovascular benefits
Full Transparency
Side effects, honestly
We believe informed patients get better outcomes. Here's exactly what clinical trials report — with context on how common each effect is and how to manage it.
Nausea
Very CommonSeverity: Mild–Moderate
Most common in first 4–8 weeks. Typically resolves as the body adapts. Eating smaller portions and avoiding high-fat foods helps significantly.
Constipation
CommonSeverity: Mild
Slowed GI transit is common with GLP-1 agonists. Increasing water, fiber, and activity level helps normalize bowel function.
Vomiting
CommonSeverity: Mild–Moderate
Most common at initiation and dose escalation. Providers can slow titration pace to minimize this effect.
Decreased Appetite
Very CommonSeverity: Intended effect
This is the primary therapeutic mechanism. Providers monitor to ensure adequate protein and nutrient intake is maintained.
Fatigue
CommonSeverity: Mild
Usually transient, often in the first weeks after dose increases. Ensuring sufficient caloric intake helps.
Diarrhea
CommonSeverity: Mild
Often transient during dose escalation. Stay well-hydrated and consider fiber supplementation.
Questions about Semaglutide
Detailed answers to the most important questions
Transparent Pricing
Consultation Fees
Physician-guided care with complete pricing clarity.
Generic Consultation
Includes Any & All Services
First Visit
$400
Follow-Up
$150
- Complete health assessment
- All service areas covered
- Personalized treatment plan
- Prescription if appropriate
Specialized Consultation
Skin, Hair, Wellness, Labs, Galleri
First Visit
$300
Follow-Up
$150
- Focused specialty review
- Lab analysis included
- Targeted treatment approach
- Follow-up protocol
Peptide Consultation
Weight loss & metabolic therapies
First Visit
$50
Follow-Up
$30
- Metabolic assessment
- GLP-1 or peptide evaluation
- Dosing strategy
- Prescription included